%0 Journal Article
%T Adjuvant therapy in stage IIIA-N2 non-small cell lung cancer after neoadjuvant concurrent chemoradiotherapy followed by surgery
%A Hong Kwan Kim
%A Hongryull Pyo
%A Jae Ill Zo
%A Jhingook Kim
%A Jong Ho Cho
%A Jong-Mu Sun
%A Keunchil Park
%A Kwhanmien Kim
%A Myung-Ju Ahn
%A Sumin Shin
%A Yong Chan Ahn
%A Yong Soo Choi
%A Young Mog Shim
%J SCIE-indexed Journal
%D 2020
%R 10.21037/jtd.2020.03.23
%X Approximately 20% of all non-small cell lung cancer (NSCLC) is stage IIIA-N2 (1). Those patients are heterogeneous in terms of disease extent and survival. Treatment options included induction chemotherapy or concurrent chemoradiotherapy (CCRT) followed by surgery, or definitive CCRT (2-7). The optimal strategy for IIIA-N2 NSCLC remains controversial and no treatment is clearly recommended (8,9)
%U http://jtd.amegroups.com/article/view/37617/html